University Hospitals Elyria Medical Center is a major community hospital in Elyria, OH. It is one of the community hospitals of the University Hospitals health system, with more than 28,000 physicians and employees across Northeast Ohio.

There are 387 beds in EMH Regional Medical Center.

During the past decade, EMH Regional Medical Center conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 8 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "EMH Regional Medical Center" #1 sponsor was "Abbott Medical Devices" with 13 trials, followed by "Boston Scientific Corporation" with 3 trials sponsored, "Medtronic Vascular" with 2 trials sponsored, "Baim Institute for Clinical Research" with 1 trials sponsored and "Cook Group Incorporated" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "EMH Regional Medical Center" #1 collaborator was "Abbott" with 1 trials as a collaborator, "Boston Scientific Corporation" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Cook Japan Incorporated" with 1 trials as a collaborator and "Cordis Corporation" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "EMH Regional Medical Center" are "Coronary Artery Disease" (13 trials), "Heart Failure" (5 trials), "Coronary Disease" (3 trials), "Coronary Restenosis" (3 trials) and "Myocardial Ischemia" (3 trials). Many other conditions were trialed in "EMH Regional Medical Center" in a lesser frequency.

Most popular intervention types in "EMH Regional Medical Center" are "Device" (17 trials), "Drug" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "TAXUS Liberté-SR" (3 trials), "TAXUS™ EXPRESS2™ Paclitaxel Eluting Coronary Stent" (2 trials), "TAXUS™ Express" (2 trials), "XIENCE V® Everolimus Eluting Coronary Stent" (2 trials) and "2.25 mm XIENCE V® Everolimus Eluting Coronary Stent System" (1 trials). Other intervention names were less common.

The vast majority of trials in "EMH Regional Medical Center" are 21 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "EMH Regional Medical Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in EMH Regional Medical Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in EMH Regional Medical Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 9 trials that are defined as “Not Applicable".